ASHLYN SMITH: Open Payments
NPI 1770124901 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$787 in 38 payments from 15 companies in 2025. Trend: 2023 $856 · 2024 $922 · 2025 $787
Food & beverage: $787
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $156 |
| Novartis Pharmaceuticals Corporation | 5 | $107 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $99 |
| PFIZER INC. | 4 | $77 |
| Actelion Pharmaceuticals US, Inc. | 3 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $58 |
| Merck Sharp & Dohme LLC | 2 | $44 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $41 |
| Edwards Lifesciences Corporation | 1 | $27 |
| Lilly USA, LLC | 1 | $25 |
Products named: LEQVIO, JARDIANCE, WAINUA, VYNDAQEL, OPSUMIT, FARXIGA, Kerendia, VERQUVO.
Industry payments across GA — which companies pay providers there.
